Sildenafil Citrate Tablet, Film Coated
Product Images NDC 80425-0410

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 80425-0410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil Citrate 100mg #6 (Sildenafil Citrate 100mg 80425 0410 01)

Description: The text provides information about a pack of Sildenafil Citrate 100mg tablets, similar to Viagra, with NDC codes, lot number, and expiry date listed. The tablets are packed by Advanced NashveT, with additional details noting the manufacturer as Ajanta Pharma. The lot expires on 5/31/2026.*

FDA Label Image

Sildenafil Citrate 100mg #12 (Sildenafil Citrate 100mg 80425 0410 02)

This is a description of Sildenafil Citrate 100mg tablets, which are a generic version of Viagra. The tablets come in a pack of 12 and have an expiration date of 5/31/2026. The manufacturer is Ajanta Pharma. The NDC number for the product is 50425-0410-02, and the source NDC is 27241-0069-10.*

FDA Label Image

Sildenafil Citrate 100mg #30 (Sildenafil Citrate 100mg 80425 0410 03)

This is a pharmaceutical product labeled as Sildenafil Citrate 100mg tablet, which is a generic equivalent of Viagra. Each pack contains 30 tablets and has a lot number and expiry date mentioned. The manufacturer of this product is Ajanta Pharma. The National Drug Code (NDC) and Source NDC are also provided for tracking purposes.*

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

Description: The text provides data on the mean change from baseline in sitting systolic blood pressure for healthy volunteers over a period of 20 hours post-dose of Sildenafil 100mg compared to a placebo. The values are recorded at 4, 8, 12, 16, and 20 hours post-dose.*

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

This text provides information about the mean sildenafil plasma concentrations in healthy male volunteers as shown in Figure 5. It suggests a study or research related to the levels of sildenafil in the blood of male participants.*

FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Percentage patients reporting improvement: - Placebo: 4% - Sidenail Tablets: 63% - Sideral Tablets (25mg): 24% - Sitdari Tablets: 2% This text provides information about the percentage of patients reporting improvement with different tablets, including Placebo, Sidenail, Sideral, and Sitdari.*

FDA Label Image

Str (Sildenafil Structure)

FDA Label Image

Figure2 (Sildenafil Fig2)

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.